CHEBI:227037 - (S)-3,4-dihydro-3-(1H-indol-3-ylmethyl)-4-methyl-1H-1,4-benzodiazepine-2,5-dione

ChEBI IDCHEBI:227037
ChEBI Name(S)-3,4-dihydro-3-(1H-indol-3-ylmethyl)-4-methyl-1H-1,4-benzodiazepine-2,5-dione
Stars
SubmitterMetaboLights
DownloadsMolfile
FormulaC19H17N3O2
Net Charge0
Average Mass319.364
Monoisotopic Mass319.13208
SMILESCN1C(=O)c2ccccc2NC(=O)[C@@H]1Cc1cnc2ccccc12
InChIInChI=1S/C19H17N3O2/c1-22-17(10-12-11-20-15-8-4-2-6-13(12)15)18(23)21-16-9-5-3-7-14(16)19(22)24/h2-9,11,17,20H,10H2,1H3,(H,21,23)/t17-/m0/s1
InChIKeyQYBGEUDXQJVALS-KRWDZBQOSA-N
Species of MetaboliteComponentSourceComments
[Malbranchea flavorosea (ncbitaxon:465703) - PubMed (30018423)
Roles Classification
Biological Role:
GABA modulator  A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act.
Application:
GABA modulator  A substance that does not act as agonist or antagonist but does affect the gamma-aminobutyric acid receptor-ionophore complex. GABA-A receptors appear to have at least three allosteric sites at which modulators act: a site at which benzodiazepines act by increasing the opening frequency of gamma-aminobutyric acid-activated chloride channels; a site at which barbiturates act to prolong the duration of channel opening; and a site at which some steroids may act.
ChEBI Ontology
Outgoing Relation(s)
(S)-3,4-dihydro-3-(1H-indol-3-ylmethyl)-4-methyl-1H-1,4-benzodiazepine-2,5-dione (CHEBI:227037) is a benzodiazepine (CHEBI:22720)
IUPAC Name 
(3S)-3-(1H-indol-3-ylmethyl)-4-methyl-1,3-dihydro-1,4-benzodiazepine-2,5-dione
Manual XrefsDatabases
78438859ChemSpider